Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-08

Clinical Trial Update: Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution [Phase 4]

View source ↗

Summary

Phase 4 trial comparing AZORGA Ophthalmic Suspension with COSOPT Ophthalmic Solution for intraocular pressure lowering and safety in open-angle glaucoma and ocu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZORGA Ophthalmic Suspension
  • COSOPT Ophthalmic Solution

Snippet

Sponsor: Alcon, a Novartis Company | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2016-12-08